Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.72 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.72 |
| ▸ | CYP4Z1 | Q86W10 | 3/20 | 0.56 |
| ▸ | PPIB | P23284 | 1/20 | 0.55 |
| ▸ | PPIA | P62937 | 1/20 | 0.55 |
| ▸ | PPID | Q08752 | 1/20 | 0.55 |
| ▸ | PPIG | Q13427 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | CYP4F11 | Q9HBI6 | 1/20 | 0.47 |
| ▸ | CYP4F12 | Q9HCS2 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6982675 | 0.98 | CYP4F2 (0.70) | CYP4F2CYP4A11CYP4Z1PPIBPPIA | |
| SCHEMBL3133486 | 0.92 | CYP4F2 (0.62) | CYP4F2CYP4A11CYP4Z1PPIBPPIA | |
| SCHEMBL68902 | 0.91 | CYP4F2 (0.85) | CYP4F2CYP4A11CYP4Z1LMNATDP1 | |
| SCHEMBL1467579 | 0.90 | CYP4F2 (0.58) | CYP4F2CYP4A11CYP4Z1PPIBPPIA | |
| SCHEMBL8819359 | 0.89 | CYP4F2 (0.72) | CYP4F2CYP4A11CYP4Z1LMNACYP1A2 | |
| Hydrochloric Acid SCHEMBL27741536 | 0.88 | CYP4Z1 (0.57) | CYP4F2CYP4A11CYP4Z1PPIBPPIA | |
| SCHEMBL9744594 | 0.88 | CYP4Z1 (0.59) | CYP4F2CYP4A11CYP4Z1PPIBPPIA | |
| Hydrochloric Acid SCHEMBL11113065 | 0.88 | CYP4F2 (0.70) | CYP4F2CYP4A11CYP4Z1CYP1A2TDP1 | |
| SCHEMBL16264858 | 0.87 | CYP4Z1 (0.58) | CYP4F2CYP4A11CYP4Z1PPIBPPIA | |
| Hydrochloric Acid SCHEMBL27344081 | 0.87 | CYP4Z1 (0.58) | CYP4F2CYP4A11CYP4Z1PPIBPPIA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111646911-A | Method for synthesizing o-aminoacetophenone | 广东莱佛士制药技术有限公司 | 2020-09-11 | — | — | CN | disclosed |
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2020-05-14 | — | — | US | disclosed |
| EP-2956444-B1 | POSACONAZOLE IMMUNOASSAYS | ARK DIAGNOSTICS INC (US) | 2018-05-30 | — | — | EP | disclosed |
| EP-2956444-B1 | POSACONAZOLE IMMUNOASSAYS | ARK DIAGNOSTICS INC (US) | 2018-05-30 | — | — | EP | disclosed |
| US-9920136-B2 | Posaconazole immunoassays | ARK DIAGNOSTICS, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-9920136-B2 | Posaconazole immunoassays | ARK DIAGNOSTICS, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-9920136-B2 | Posaconazole immunoassays | ARK DIAGNOSTICS, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| CN-107176922-A | A kind of synthetic method of quinoline | 湖南华腾制药有限公司 | 2017-09-19 | — | — | CN | disclosed |
| EP-2956444-A1 | POSACONAZOLE IMMUNOASSAYS | ARK Diagnostics, Inc. (US) | 2015-12-23 | — | — | EP | disclosed |
| EP-2942349-A1 | ENZYME MODULATORS AND TREATMENTS | Deciphera Pharmaceuticals, LLC (US) | 2015-11-11 | — | — | EP | disclosed |
| EP-0052296-A1 | Glutamine derivatives usable for curing immune diseases, methods for their preparation and compositions comprising said derivatives | MITSUBISHI KASEI CORPORATION (JP) | 1982-05-26 | — | — | EP | disclosed |
| US-4318914-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoro-alkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1982-03-09 | — | — | US | disclosed |
| US-4310545-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoroalkylamino) phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| US-4305959-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoro-alkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1981-12-15 | — | — | US | disclosed |
| US-4281019-A | 4-[(Unsaturated or cyclopropylated alkyl)amino]phenyl compounds useful as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4259352-A | 4-[Cycloalkyl- or cycloalkenyl-amino(cycloalkyl- or cycloalkenyl-alkenyl)amino]phenyl compounds, useful as hypolipidemic and antiatherosclerotic agents | AMERICAN CYANAMID COMPANY (US) | 1981-03-31 | — | — | US | disclosed |
| US-4211783-A | Hypolipidemic and antiatherosclerotic novel 4-(aralkyl- and heteroarylalkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1980-07-08 | — | — | US | disclosed |
| US-4205085-A | Hypolipidemic and antiatherosclerotic 4-(polyfluoroalkylamino)phenyl compounds | AMERICAN CYANAMID COMPANY (US) | 1980-05-27 | — | — | US | disclosed |
| EP-0003663-A2 | Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them | AMERICAN CYANAMID COMPANY (US) | 1979-08-22 | — | — | EP | disclosed |
| US-4113871-A | HYPOGLYCEMICALLY AND HYPOLIPIDEMICALLY ACTIVE DERIVATIVES OF PHENYL-ALKANE-CARBOXYLIC ACIDS | BOEHRINGER MANNHEIM GMBH (DE) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200148937-A1 | INHIBITING HYDROCARBON HYDRATE AGGLOMERATION | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AHR, SHH | CYP4F2 914/4885CYP4A11 776/4885CYP4Z1 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.